Technical Analysis for ALBO - Albireo Pharma, Inc.

Grade Last Price % Change Price Change
F 32.14 1.10% 0.35
ALBO closed up 1.1 percent on Thursday, April 22, 2021, on 1.61 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ALBO trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Touch Weakness 1.10%
Oversold Stochastic Weakness 1.10%
Expansion Breakdown Bearish Swing Setup 2.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.00%
Reversal New Lows Setup Bearish Swing Setup 2.00%
Stochastic Reached Oversold Weakness 2.00%
Older End-of-Day Signals for ALBO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 5 hours ago
Up 3% about 7 hours ago
10 DMA Resistance about 9 hours ago
60 Minute Opening Range Breakout about 9 hours ago
Rose Above Previous Day's High about 9 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Albireo Pharma, Inc. Description

Albireo Limited is a holding company for Albireo AB, a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo’s clinical pipeline includes two Phase 2 product candidates and one Phase 3 product candidate. Albireo was spun out from AstraZeneca in 2008 and is backed by top-tier life science investors such as Phase4 Ventures, TPG Biotech, TVM Capital Life Science and Aberdeen Asset Management, as well as AstraZeneca. Albireo Limited is incorporated and registered in England and Wales, and its wholly owned subsidiaries are located in Gothenburg, Sweden and Boston, Massachusetts. For more information on Albireo, please visit www.albireopharma.com


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Acid Gastrointestinal Disorders Liver Disease Gastrointestinal Disease Gastrointestinal Diseases Aberdeen Asset Management Liver Diseases Tpg Liver Bile Acid

Is ALBO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.0
52 Week Low 20.24
Average Volume 160,944
200-Day Moving Average 34.18
50-Day Moving Average 35.18
20-Day Moving Average 33.39
10-Day Moving Average 32.36
Average True Range 1.60
ADX 15.21
+DI 18.44
-DI 21.76
Chandelier Exit (Long, 3 ATRs ) 31.69
Chandelier Exit (Short, 3 ATRs ) 35.52
Upper Bollinger Band 35.78
Lower Bollinger Band 31.00
Percent B (%b) 0.24
BandWidth 14.33
MACD Line -0.95
MACD Signal Line -0.90
MACD Histogram -0.0514
Fundamentals Value
Market Cap 613.14 Million
Num Shares 19.1 Million
EPS -5.23
Price-to-Earnings (P/E) Ratio -6.15
Price-to-Sales 43.43
Price-to-Book 3.27
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.72
Resistance 3 (R3) 34.66 33.75 34.29
Resistance 2 (R2) 33.75 33.09 33.78 34.15
Resistance 1 (R1) 32.94 32.68 33.35 33.00 34.00
Pivot Point 32.03 32.03 32.23 32.06 32.03
Support 1 (S1) 31.22 31.37 31.63 31.28 30.28
Support 2 (S2) 30.31 30.96 30.34 30.13
Support 3 (S3) 29.50 30.31 29.99
Support 4 (S4) 29.56